Literature DB >> 22234083

Modified duval procedure for small-duct chronic pancreatitis without head dominance.

Takatsugu Oida1, Osamu Aramaki, Hisao Kano, Kenji Mimatsu, Atsushi Kawasaki, Youichi Kuboi, Nobutada Fukino, Kazutoshi Kida, Sadao Amano.   

Abstract

BACKGROUND/AIMS: In the case of small-duct chronic pancreatitis, surgery for pain relief is broadly divided into resection and drainage procedures. These procedures should be selected according to the location of dominant lesion, diameter of the pancreatic duct and extent of the disease. The appropriate procedure for the treatment of small-duct chronic pancreatitis, especially small-duct chronic pancreatitis without head dominance, remains controversial. We developed the modified Duval procedure for the treatment of small-duct chronic pancreatitis without head dominance and determined the efficacy of this procedure.
METHODOLOGY: We retrospectively studied 14 patients who underwent surgical drainage with or without pancreatic resection for chronic pancreatitis with small pancreatic duct (<7mm) without head dominance. These patients were divided into 2 groups; the modified Puestow procedure group and the modified Duval procedure group.
RESULTS: No complications occurred in the modified Duval group. In the modified Puestow procedure group, complete and partial pain relief were observed in 62.5%, and 37.5% of patients respectively. In contrast, complete pain relief was observed in all the patients in the modified Duval procedure group.
CONCLUSIONS: Our modified Duval procedure is useful and should be considered the appropriate surgical technique for the treatment of small-duct chronic pancreatitis without head dominance.

Entities:  

Mesh:

Year:  2011        PMID: 22234083     DOI: 10.5754/hge09603

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

Review 1.  The Surgeon's Role in Treating Chronic Pancreatitis and Incidentally Discovered Pancreatic Lesions.

Authors:  Vikrom K Dhar; Brent T Xia; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.